BlackRock’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $204M | Sell |
|
|||||
|
2025
Q2 | $158M | Sell |
|
|||||
|
2025
Q1 | $227M | Sell |
|
|||||
|
2024
Q4 | $263M | Buy |
|
|||||
|
2024
Q3 | $279M | Buy |
|
|||||
|
2024
Q2 | $242M | Buy |
|
|||||
|
2024
Q1 | $269M | Sell |
|
|||||
|
2023
Q4 | $326M | Buy |
|
|||||
|
2023
Q3 | $255M | Buy |
|
|||||
|
2023
Q2 | $262M | Buy |
|
|||||
|
2023
Q1 | $219M | Sell |
|
|||||
|
2022
Q4 | $246M | Buy |
|
|||||
|
2022
Q3 | $208M | Sell |
|
|||||
|
2022
Q2 | $217M | Buy |
|
|||||
|
2022
Q1 | $186M | Sell |
|
|||||
|
2021
Q4 | $229M | Buy |
|
|||||
|
2021
Q3 | $187M | Sell |
|
|||||
|
2021
Q2 | $196M | Sell |
|
|||||
|
2021
Q1 | $213M | Sell |
|
|||||
|
2020
Q4 | $505M | Buy |
|
|||||
|
2020
Q3 | $296M | Sell |
|
|||||
|
2020
Q2 | $336M | Buy |
|
|||||
|
2020
Q1 | $196M | Buy |
|
|||||
|
2019
Q4 | $203M | Buy |
|
|||||
|
2019
Q3 | $166M | Buy |
|
|||||
|
2019
Q2 | $232M | Buy |
|
|||||
|
2019
Q1 | $228M | Buy |
|
|||||
|
2018
Q4 | $158M | Buy |
|
|||||
|
2018
Q3 | $198M | Buy |
|
|||||
|
2018
Q2 | $250M | Buy |
|
|||||
|
2018
Q1 | $227M | Buy |
|
|||||
|
2017
Q4 | $197M | Buy |
|
|||||
|
2017
Q3 | $202M | Buy |
|
|||||
|
2017
Q2 | $119M | Sell |
|
|||||
|
2017
Q1 | $85.3M | Buy |
|
|||||
|
2016
Q4 | $59K | Sell |
|
|||||
|
2016
Q3 | $197K | Buy |
|
|||||
|
2016
Q2 | $144K | Buy |
|
|||||
|
2016
Q1 | $69K | Buy |
|
|||||
|
2015
Q4 | $37K | Buy |
|
|||||
|
2015
Q3 | $41K | Hold |
|
|||||
|
2015
Q2 | $41K | Buy |
|